Replies to post #26421 on Intellipharmaceutics International Inc. (IPCI)

[Samsa]

J cali....To answer your question the latest information is a request from Purdue to enter 9 more lawyers as "Pro Hac Vice Appearance" which means these lawyers would not normally be allowed to appear before this judge. you would file this in the event say you had a law firm from California in the 9th circuit court and they were not permitted to represent clients in say the 3rd circuit court, you would file this motion in order to allow those attorneys to argue in this case. It does not grant the attorney any special privileges beyond the case at hand.

what you are seeing is the order signed by the judge permitting this for Purdue.

[Tekterra]

J_Cali, I think you hit it on the nail's head. IPCI need a partnership to advance it's more profitable pipeline. The situation with the stock doesn't improve much until that happens either with Rexista, PODRAS, or Lyrica.

IPCI may go cash positive but that doesn't help them move the pipe line forward. And if they don't move the pipeline forward, they aren't going to attract long term investors. Unlike Rexista, Lyrica requires trails may cost in 10s of millions. This is where investors look for the long term growth potential. If IPCI had even just 20 million cash reserve, we would be looking at a different picture.

[wimuskyfisherman]

J Cali- As far as I know, IPCI does not have a version of Lyrica. They have Regabatin- which is once a day Lyrica. So I do not think they can file an ANDA on Regabatin. It is not exactly the same as Lyrica. For now I believe they are stuck with the NDA path they are on. Pfizer is developing a once a day version of Lyrica as well. If Pfizer does succeed, then maybe IPCI can file and ANDA based on Pfizer's approved version of once a day Lyrica.